RESEARCH BASE

Search 3,717 documents across 34 fields — every claim tier-rated by evidence

3,717 documents 34 sections 47,686 citations 34,596+ keywords indexed 4 evidence tiers

8 results for "MDMA"

Y_5_20 Verified Altered States

Y_5_20 — MDMA Pharmacology: Entactogen Mechanisms, Therapeutic Potential, and Risks

MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy or molly, is a synthetic entactogen (from Latin tactus, "touching within") that produces profound feelings of emotional closeness, empathy, trust, and w

MDMA ecstasy entactogen empathogen serotonin PTSD therapy
X_2_03 Medicine & Healing

X_2_03 — Psychedelic Medicine: Clinical Evidence and Renaissance

The psychedelic renaissance — the resurgence of clinical research into psychedelic compounds after decades of prohibition — represents one of the most significant paradigm shifts in modern psychiatry. Psilocybin for trea

psychedelic therapy psilocybin MDMA LSD ketamine DMT
X_5_26 Verified Medicine & Healing

X_5_26 — Psychedelic Medicine: The Johns Hopkins Center and the Therapeutic Renaissance

The psychedelic therapy renaissance — centered at the Johns Hopkins Center for Psychedelic and Consciousness Research (established 2019, originally launched as a research program in 2000) — represents one of the most sig

psychedelic medicine psilocybin johns hopkins MDMA therapeutic clinical trials
Z_4_06 Verified Molecular Biology

Z_4_06 — Psychedelic Neurochemistry: 5-HT2A, Tryptamines, and Molecular Mechanisms

Psychedelic neurochemistry — the molecular-level study of how psychedelic compounds alter brain function to produce their characteristic effects (visual hallucinations, synesthesia, ego dissolution, mystical-type experie

psychedelics 5-HT2A receptor serotonin tryptamines psilocybin LSD
Y_1_04 Altered States

Y_1_04 — Psychedelic Renaissance — Clinical Research and Consciousness

The psychedelic renaissance — a resurgence of rigorous scientific research on psychedelic substances after decades of prohibition — has produced some of the most significant findings in 21st-century psychiatry and consci

psychedelic renaissance psilocybin MDMA therapy ketamine DMT ayahuasca
Y_1_16 Verified Altered States

Y_1_16 — Psychedelic Legal Frameworks: Regulation, Decriminalization, and Therapeutic Access

The legal status of psychedelic substances — including psilocybin, LSD, MDMA, DMT/ayahuasca, mescaline, and ibogaine — has undergone dramatic shifts since the mid-20th century, moving from unregulated research compounds

psychedelic law psilocybin MDMA Schedule I decriminalization right to try
H_4_06 Suppression & Thesis

H_4_06 — Suppression of Psychedelic Research (1960s–2000s)

From the late 1940s through the mid-1960s, psychedelic substances — particularly LSD (lysergic acid diethylamide) and psilocybin — were the subject of extensive legitimate scientific research, with over 1,000 peer-review

psychedelics Schedule I LSD psilocybin MDMA Controlled Substances Act
ZE_3_06 Verified Ethics & Applied Philosophy

ZE_3_06 — Ethics of Psychedelic Research and Therapy

The ethics of psychedelic research and therapy addresses the unique moral challenges posed by substances that profoundly alter consciousness in therapeutic, religious, and research contexts. After a 40-year research mora

psychedelic ethics psilocybin MDMA ayahuasca informed consent clinical trials